Keller L

No ORCID on file · 4 papers in corpus
2024
Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-024-01322-7

Research questionTo determine whether the use of oral dydrogesterone (DYD) in luteal phase support (LPS) during an artificial cycle provides equivalent clinical and ongoing pregnancy, delivery and miscarriage rates as micronized vaginal pro…

2022
Polycystic ovary syndrome phenotype does not have impact on oocyte morphology.
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00874-2

PurposeThe primary objective of the present study of women participating in an ICSI program was to determine whether the morphologic quality of oocytes was related to the polycystic ovary syndrome (PCOS) phenotype.MethodsWe performed a retr…

2022
Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot study.
Frontiers in endocrinology ·doi:10.3389/fendo.2022.1039579

ObjectiveThe need of luteal support after FET is no longer to be proven. Different routes of progesterone administration are available with interindividual differences in metabolization and serum progesterone levels, the latter being highly…

other 2021
Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2021.04.020

RESEARCH QUESTION: What are ovarian stimulation cycle outcomes and acceptance rates of an oocyte accumulation programme in young women with benign ovarian tumour (BOT)? DESIGN: Retrospective cohort study conducted at the Academic Assisted …